Tumor Budding Score Is a Strong and Independent Prognostic Factor in Patients With Pancreatic Ductal Adenocarcinoma: An Evaluation of Whole Slide Pathology Images of Large Sections

被引:2
作者
Jiang, Hui [1 ]
Yang, Yelin [1 ]
Qian, Yuping [1 ]
Shao, Chengwei [2 ]
Lu, Jianping [2 ]
Bian, Yun [2 ]
Zheng, Jianming [1 ]
机构
[1] Naval Mil Med Univ, Changhai Hosp, Dept Pathol, Shanghai, Peoples R China
[2] Naval Med Univ, Changhai Hosp, Dept Radiol, Shanghai, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
基金
美国国家科学基金会; 上海市自然科学基金;
关键词
pancreatic neoplasm; carcinoma; tumor budding; prognosis; survival; neoplasm staging; CANCER; VALIDATION; EXPRESSION; INVASION;
D O I
10.3389/fonc.2021.740212
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveWe aimed to develop the tumor budding (TB) score and to explore the association between the TB score and overall survival (OS) in patients with pancreatic ductal adenocarcinoma (PDAC). MethodsIn this retrospective study, 130 consecutive patients with PDAC underwent surgical resection between July 2016 and March 2019. The location and counts of TB were assessed based on the digitalized whole slide hematoxylin and eosin images. The TB score was achieved using the Cox regression equation. The cutoff point for the TB score was determined by X-tile. Univariate and multivariate Cox regression models were used to analyze the association between the TB score and OS. ResultsThe TB score was 0.49 (range = 0-1.08), and the best cutoff for the TB score was 0.62. The duration of survival in individuals with a low TB score [median = 21.8 months, 95% confidence interval (CI) = 15.43-25.50] was significantly longer than that in those with a high TB score (median = 11.33 months, 95% CI = 9.8-14.22). Univariate analysis revealed that the TB score was significantly associated with OS [hazard ratio (HR) = 2.71, 95% CI = 1.48-4.96, p = 0.001]. Multivariate analysis revealed a strong and independent association between the TB score and OS (HR = 2.35, 95% CI = 1.27-4.33, p = 0.03). The high TB score group had a 2.14 times higher mortality than the low TB score group. ConclusionThe TB score is strongly and independently associated with the risk of OS in PDAC.
引用
收藏
页数:10
相关论文
共 29 条
  • [11] Tumor Budding and Prognosis in Gastric Adenocarcinoma
    Kemi, Niko
    Eskuri, Maarit
    Ikalainen, Julia
    Karttunen, Tuomo J.
    Kauppila, Joonas H.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2019, 43 (02) : 229 - 234
  • [12] Molecular mechanisms of epithelial-mesenchymal transition
    Lamouille, Samy
    Xu, Jian
    Derynck, Rik
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2014, 15 (03) : 178 - 196
  • [13] Prognostic Role of High-Grade Tumor Budding in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis with a Focus on Epithelial to Mesenchymal Transition
    Lawlor, Rita T.
    Veronese, Nicola
    Nottegar, Alessia
    Malleo, Giuseppe
    Smith, Lee
    Demurtas, Jacopo
    Cheng, Liang
    Wood, Laura D.
    Silvestris, Nicola
    Salvia, Roberto
    Scarpa, Aldo
    Luchini, Claudio
    [J]. CANCERS, 2019, 11 (01)
  • [14] Mismatch repair protein expression and intratumoral budding in rectal cancer are associated with an increased pathological complete response to preoperative chemoradiotherapy: A case-control study
    Lino-Silva, Leonardo S.
    Gamboa-Dominguez, Armando
    Zuniga-Tamayo, Diego
    Salcedo-Hernandez, Rosa A.
    Cetina, Lucely
    Cantu-de-Leon, David
    [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2018, 9 (07): : 133 - 139
  • [15] Digital slide viewing for primary reporting in gastrointestinal pathology: a validation study
    Loughrey, Maurice B.
    Kelly, Paul J.
    Houghton, Oisin P.
    Coleman, Helen G.
    Houghton, Joseph P.
    Carson, Anne
    Salto-Tellez, Manuel
    Hamilton, Peter W.
    [J]. VIRCHOWS ARCHIV, 2015, 467 (02) : 137 - 144
  • [16] Tumour budding in solid cancers
    Lugli, Alessandro
    Zlobec, Inti
    Berger, Martin D.
    Kirsch, Richard
    Nagtegaal, Iris D.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (02) : 101 - 115
  • [17] Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016
    Lugli, Alessandro
    Kirsch, Richard
    Ajioka, Yoichi
    Bosman, Fred
    Cathomas, Gieri
    Dawson, Heather
    El Zimaity, Hala
    Flejou, Jean-Francois
    Hansen, Tine Plato
    Hartmann, Arndt
    Kakar, Sanjay
    Langner, Cord
    Nagtegaal, Iris
    Puppa, Giacomo
    Riddell, Robert
    Ristimaki, Ari
    Sheahan, Kieran
    Smyrk, Thomas
    Sugihara, Kenichi
    Terris, Benoit
    Ueno, Hideki
    Vieth, Michael
    Zlobec, Inti
    Quirke, Phil
    [J]. MODERN PATHOLOGY, 2017, 30 (09) : 1299 - 1311
  • [18] Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients
    Lugli, Alessandro
    Vlajnic, Tatjana
    Giger, Olivier
    Karamitopoulou, Eva
    Patsouris, Efstratios S.
    Peros, George
    Terracciano, Luigi M.
    Zlobec, Inti
    [J]. HUMAN PATHOLOGY, 2011, 42 (12) : 1833 - 1840
  • [19] Image analysis and machine learning in digital pathology: Challenges and opportunities
    Madabhushi, Anant
    Lee, George
    [J]. MEDICAL IMAGE ANALYSIS, 2016, 33 : 170 - 175
  • [20] High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer
    Marx, Andreas H.
    Mickler, Claudius
    Sauter, Guido
    Simon, Ronald
    Terracciano, Luigi M.
    Izbicki, Jakob R.
    Clauditz, Till S.
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2020, 35 (02) : 259 - 268